Inside AtriCure: Prange’s Partial Sale Signals Steady Insider Confidence
Insider sale at AtriCure: Karen Prange sells 3,000 shares, showing routine portfolio rebalancing and confidence in the company’s medical‑device pipeline.
3 minutes to read
AtriCure Inc
Inside AtriCure’s Mid‑May Insider Sale: What It Means for Investors
Insight into AtriCure’s mid‑May insider sale: CSO’s 5,000 shares sold near market highs show routine liquidity, not a bearish warning.
3 minutes to read
Insider Buying Surge at AtriCure Signals Strong Confidence in Q4 Earnings & Growth
Insider buying spurs confidence in AtriCure (ATR) after 13% revenue lift and strong Q4 earnings, highlighting executives’ long‑term commitment.
4 minutes to read